Nosocomial Acinetobacter pneumonia

Carlos M Luna1, Patricia K Aruj

  • 1Department of Internal Medicine, Pulmonary Diseases Division, Hospital de Clínicas, Universidad de Buenos Aires, Argentina. cymluna@advancedsl.com.ar

Respirology (Carlton, Vic.)
|November 8, 2007
PubMed

Insights

Acinetobacter spp. causes hospital-acquired pneumonia, especially in ventilated patients, due to its resistance and environmental persistence. Strict infection control and appropriate antibiotic treatment are crucial for managing outbreaks.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Hospital Epidemiology

Background:

  • Acinetobacter spp., particularly A. baumannii, is a significant cause of nosocomial pneumonia in mechanically ventilated patients.
  • This bacterium exhibits intrinsic and acquired antimicrobial resistance and environmental persistence, leading to difficult-to-control outbreaks.
  • Nosocomial infections with Acinetobacter spp. are often linked to cross-transmission from the hospital environment or staff, rather than endogenous sources.

Purpose of the Study:

  • To highlight Acinetobacter spp. as a growing threat in hospital-acquired infections, particularly ventilator-associated pneumonia (VAP).
  • To discuss the contributing factors, clinical implications, and effective management strategies for Acinetobacter spp. VAP.
  • To emphasize the importance of infection control measures in preventing and managing outbreaks.

Main Methods:

  • Literature review and synthesis of existing data on Acinetobacter spp. epidemiology, resistance patterns, and clinical impact.
  • Analysis of risk factors associated with Acinetobacter spp. VAP, including hospitalization duration and prior antibiotic use.
  • Review of current antimicrobial treatment options and infection control strategies.

Main Results:

  • Acinetobacter spp. is the second most common Gram-negative cause of VAP, associated with high morbidity and mortality.
  • Risk factors for Acinetobacter spp. VAP include prolonged hospitalization, mechanical ventilation, and prior antibiotic exposure.
  • Effective antimicrobial agents include imipenem/cilastatin, amikacin, colistin, ampicillin/sulbactam, and tigecycline; monotherapy may suffice in uncomplicated cases.

Conclusions:

  • Strict infection control measures, including patient isolation, are paramount to prevent Acinetobacter spp. transmission and control outbreaks.
  • Differentiating between colonization and infection is critical for appropriate patient management.
  • The environmental persistence of Acinetobacter spp. poses a continuous challenge for healthcare facilities, necessitating robust infection prevention programs.

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Acute Pyelonephritis I: Introduction01:27

Acute Pyelonephritis I: Introduction

Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such as Proteus,...
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic01:26

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic

Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...